Skip to main content
All lobbying filings

Apco Worldwide LLC

Apco Worldwide LLC filed a Q4 report for Hikma Pharmaceuticals USA Inc. on January 15, 2026, reporting $40,000 in lobbying income.

Lobbying for Hikma Pharmaceuticals USA Inc. · Pharmaceutical manufacturer

As filed: APCO WORLDWIDE LLC for HIKMA PHARMACEUTICALS USA INC.

All filings by Apco Worldwide LLC · Everything Hikma Pharmaceuticals USA Inc. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 15, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
New Jersey

Official filing document

 Lobbyists on this filing 2
  • ALLISON PARKER-LAGOO
    Previously held: Assistant to the Chief of Staff, Sen. Hagan
  • DAN SCANDLING
    Previously held: Chief of Staff & Press Secretary, Rep. Bateman

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues

Trade policies impacting domestic generic pharmaceutical manufacturing

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem